- Home
- VRA vs CTSO Comparison
VRA vs CTSO Comparison
Compare VRA & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VRA
- CTSO
- Stock Information
- Founded
- VRA 1982
- CTSO 1997
- Country
- VRA United States
- CTSO United States
- Employees
- VRA N/A
- CTSO N/A
- Industry
- VRA Apparel
- CTSO Medical/Dental Instruments
- Sector
- VRA Consumer Discretionary
- CTSO Health Care
- Exchange
- VRA Nasdaq
- CTSO Nasdaq
- Market Cap
- VRA 69.2M
- CTSO 68.2M
- IPO Year
- VRA 2010
- CTSO N/A
- Fundamental
- Price
- VRA $1.87
- CTSO $0.87
- Analyst Decision
- VRA Strong Buy
- CTSO Strong Buy
- Analyst Count
- VRA 2
- CTSO 3
- Target Price
- VRA $4.00
- CTSO $4.67
- AVG Volume (30 Days)
- VRA 200.2K
- CTSO 138.6K
- Earning Date
- VRA 06-11-2025
- CTSO 05-14-2025
- Dividend Yield
- VRA N/A
- CTSO N/A
- EPS Growth
- VRA N/A
- CTSO N/A
- EPS
- VRA N/A
- CTSO N/A
- Revenue
- VRA $371,967,000.00
- CTSO $35,594,520.00
- Revenue This Year
- VRA N/A
- CTSO $18.72
- Revenue Next Year
- VRA $3.71
- CTSO $19.75
- P/E Ratio
- VRA N/A
- CTSO N/A
- Revenue Growth
- VRA N/A
- CTSO 14.51
- 52 Week Low
- VRA $1.72
- CTSO $0.70
- 52 Week High
- VRA $8.32
- CTSO $1.61
- Technical
- Relative Strength Index (RSI)
- VRA 43.13
- CTSO 34.05
- Support Level
- VRA $1.72
- CTSO $0.87
- Resistance Level
- VRA $2.04
- CTSO $1.16
- Average True Range (ATR)
- VRA 0.13
- CTSO 0.06
- MACD
- VRA 0.02
- CTSO -0.02
- Stochastic Oscillator
- VRA 39.47
- CTSO 0.34
About VRA Vera Bradley Inc.
Vera Bradley Inc designs women's handbags, travel items, and accessories. Each category comprises a substantial component of total sales, with the bags category comprising the most. most of the company's sales are made directly to customers through Vera Bradley's retail stores and e-commerce sites. The company also has a substantial wholesale business selling to specialty retail and department stores. Almost all company sales are in the United States. Vera Bradley uses third-party manufacturers in Asia to produce its products, and the company distributes the products through its distribution center in Indiana. The Company has three reportable segments: Vera Bradley Direct, Vera Bradley Indirect, and Pura Vida. The majority of revenue is from the Vera Bradley Direct segment.
About CTSO Cytosorbents Corporation
CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.